The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 3,927,205 | 308,500 | SH | SOLE | 308,500 | 0 | 0 | |||
ACELYRIN INC | COM | 00445A100 | 42,166,223 | 4,146,138 | SH | SOLE | 4,146,138 | 0 | 0 | |||
APPLIED THERAPEUTICS | COM | 03828A101 | 2,223,570 | 893,000 | SH | SOLE | 893,000 | 0 | 0 | |||
BIODESIX | COM | 09075X108 | 599,070 | 363,073 | SH | SOLE | 363,073 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 11,418,390 | 439,000 | SH | SOLE | 439,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 09075X108 | 2,439,225 | 92,500 | SH | SOLE | 92,500 | 0 | 0 | |||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 14,086,450 | 1,205,000 | SH | SOLE | 1,205,000 | 0 | 0 | |||
CODEXIS INC | COM | 192005106 | 2,114,721 | 1,118,900 | SH | SOLE | 1,118,900 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 11,003,800 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | |||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 5,016,071 | 875,405 | SH | SOLE | 875,405 | 0 | 0 | |||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 10,134,226 | 2,430,270 | SH | SOLE | 2,430,270 | 0 | 0 | |||
FORTRESS BIOTECH INC | COM | 34960Q109 | 580,600 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | |||
GERON CORP | COM | 374163103 | 4,059,800 | 1,915,000 | SH | SOLE | 1,915,000 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 3,959,298 | 4,754,200 | SH | SOLE | 4,754,200 | 0 | 0 | |||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 3,098,704 | 8,000,000 | SH | SOLE | 8,000,000 | 0 | 0 | |||
HARROW HEALTH INC | COM | 415858109 | 54,534,150 | 3,795,000 | SH | SOLE | 3,795,000 | 0 | 0 | |||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 8,404,270 | 311,500 | SH | SOLE | 311,500 | 0 | 0 | |||
IGM BIOSCIIENCES INC | COM | 449585108 | 2,179,350 | 261,000 | SH | SOLE | 261,000 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,775,500 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,815,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
KEROS THERAPEUTICS INC | COM | 492327101 | 11,489,552 | 360,400 | SH | SOLE | 360,400 | 0 | 0 | |||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 505,750 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | |||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 3,351,575 | 848,500 | SH | SOLE | 848,500 | 0 | 0 | |||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | 3,618,238 | 570,700 | SH | SOLE | 570,700 | 0 | 0 | |||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 4,701,200 | 584,000 | SH | SOLE | 584,000 | 0 | 0 | |||
MORPHOSYS AG | SPONSORED ADS | 617760202 | 8,127,034 | 1,209,380 | SH | SOLE | 1,209,380 | 0 | 0 | |||
NYXOAH S A | SHS | B6S7WD106 | 3,115,367 | 441,896 | SH | SOLE | 441,896 | 0 | 0 | |||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 20,309,520 | 6,468,000 | SH | SOLE | 6,468,000 | 0 | 0 | |||
PRECIGEN INC | COM | 74017N105 | 1,318,470 | 928,500 | SH | SOLE | 928,500 | 0 | 0 | |||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 4,496,632 | 2,692,594 | SH | SOLE | 2,692,594 | 0 | 0 | |||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 90,000 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 14,970,025 | 653,000 | SH | SOLE | 653,000 | 0 | 0 | |||
TELA BIO INC | COM | 872381108 | 6,000,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 15,800,400 | 1,890,000 | SH | SOLE | 1,890,000 | 0 | 0 | |||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 848,082 | 4,764,508 | SH | SOLE | 4,764,508 | 0 | 0 | |||
TREVI THERAPEUTICS INC | COM | 89532M101 | 3,718,862 | 1,705,900 | SH | SOLE | 1,705,900 | 0 | 0 | |||
UROGEN PHARMA LTD | COM | M96088105 | 4,483,200 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 4,588,200 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | |||
VERASTEM INC | COM NEW | 92337C203 | 1,718,682 | 211,400 | SH | SOLE | 211,400 | 0 | 0 | |||
XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 725,400 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | |||
XOMA CORP DEL | COM NEW | 98419J206 | 3,867,705 | 274,500 | SH | SOLE | 274,500 | 0 | 0 |